FDA: Lamotrigine Tied to Rare, Serious Immune System Reaction FDA: Lamotrigine Tied to Rare, Serious Immune System Reaction

The FDA will add a warning about the risk for hemophagocytic lymphohistiocytosis to the prescribing information on lamotrigine drug labels.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news